2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-
2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-(667463-82-3)
- Name: 2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-
- Synonyms:
- Molecular Formula:C16H11N3O2
- Molecular Weight:277.282
- CAS Registry Number:667463-82-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.667463-82-3 Indirubin-3'-monoxime
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.667463-82-3 2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.667463-82-3 Indirubin-3鈥?oxime;667463-82-3
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
CAS No.667463-82-3 Indirubin-3'-oxime
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
CAS No.667463-82-3 indirubin-3'-monoxime
Assay:97% Application:Drug R&D
Min. Order:0
Supplier:Suzhou Sibian Chemical Technology Co., Ltd [
China (Mainland)]

Other Product
- 667463-25-4/Pyridine, 2-[(Z)-(chlorostibylene)(trimethylsilyl)methyl]-
- 667463-27-6/1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2- nitro-, (1Z)-
- 667463-60-7/2H-Indol-2-one, 6-bromo-3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3Z)-
- 667463-61-8/2H-Indol-2-one, 4-chloro-3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-
- 667463-63-0/2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3- dihydro-, (3Z)-
- 667463-64-1/6-BroMo-1-Methylisatin
- 667463-65-2/2H-Indol-2-one, 3-(6-bromo-1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3Z)-
- 667463-66-3/2H-Indol-2-one, 3-[(3E)-6-bromo-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3- dihydro-, (3Z)-
- 667463-67-4/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-6-bromo-1, 3-dihydro-1-methyl-, (3Z)-
- 667463-68-5/6-BroMo-5-nitroindoline-2,3-dione
- 667463-69-6/2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-6-fluoro-1,3-dihydro-, (3Z)-
- 667463-70-9/2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-6-iodo-, (3Z)-
- 667463-71-0/2H-Indol-2-one, 6-chloro-3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3Z)-
- 667463-72-1/2H-Indol-2-one, 5,6-dichloro-3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3Z)-
- 667463-73-2/2H-Indol-2-one, 6-bromo-3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-5-methyl -, (3Z)-
- 667463-75-4/2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-6-ethenyl-1,3-dihydro-, (3Z)-
- 667463-77-6/2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-6- iodo-, (3Z)-
- 667463-79-8/2H-Indol-2-one, 5,6-dichloro-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1 ,3-dihydro-, (3Z)-
- 667463-80-1/2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3- dihydro-5-methyl-, (3Z)-
- 667463-82-3/2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-
- 667463-83-4/2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-6-ethenyl-1,3- dihydro-, (3Z)-
- 667463-84-5/2H-Indol-2-one, 3-[(3E)-1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-
- 667463-85-6/(2'Z,3'E)-6-BROMOINDIRUBIN-3'-ACETOXIME
- 667463-86-7/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-6-fluoro-1,3 -dihydro-, (3Z)-
- 667463-87-8/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro -6-iodo-, (3Z)-
- 667463-88-9/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-6-chloro-1, 3-dihydro-, (3Z)-
- 667463-89-0/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-5,6-dichlor o-1,3-dihydro-, (3Z)-
- 667463-90-3/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-6-bromo-1, 3-dihydro-5-methyl-, (3Z)-
- 667463-92-5/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro -, (3Z)-
- 667463-93-6/2H-Indol-2-one, 3-[(3E)-3-[(acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene]-6-ethenyl-1, 3-dihydro-, (3Z)-